Effect of Chitosan and Liposome Nanoparticles as Adjuvant Codelivery on the Immunoglobulin G Subclass Distribution in a Mouse Model.

about

Effect of Chitosan and Liposome Nanoparticles as Adjuvant Codelivery on the Immunoglobulin G Subclass Distribution in a Mouse Model.

Item

http://www.wikidata.org/entity/Q41056704

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Effect of Chitosan and Liposom ...... Distribution in a Mouse Model.

@en

type

Item

label

Effect of Chitosan and Liposom ...... Distribution in a Mouse Model.

@en

prefLabel

Effect of Chitosan and Liposom ...... Distribution in a Mouse Model.

@en

P1476

Effect of Chitosan and Liposom ...... Distribution in a Mouse Model

@en

P2093

Agus Haryono

http://www.w3.org/2001/XMLSchema#string

Korrie Salsabila

http://www.w3.org/2001/XMLSchema#string

Sri Budi Harmami

http://www.w3.org/2001/XMLSchema#string

Witta Kartika Restu

http://www.w3.org/2001/XMLSchema#string

P2860

Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators

Preparation and characterization of chitosan-based nanoparticles.

Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice

Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.

Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine

Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.

Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.

A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media.

Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status.

Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice.

P304

9125048

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/9125048

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Dodi Safari

P577

2017-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28758135

http://www.w3.org/2001/XMLSchema#string

P932

5516754

http://www.w3.org/2001/XMLSchema#string